Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis.

Szczegóły
Abstrakt

Tytuł:: Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis.
Autorzy:: Polyzos SA; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Kountouras J; Second Medical Clinic, School of Medicine, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.
Anastasilakis AD; Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
Źródło:: Metabolism: clinical and experimental [Metabolism] 2021 Aug; Vol. 121, pp. 154818. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji:: Letter
Język:: English
Imprint Name(s):: Publication: New York, NY : Elsevier Inc.
Original Publication: New York, Grune & Stratton.
MeSH Terms:: Meta-Analysis as Topic*
Fibronectins/*blood
Non-alcoholic Fatty Liver Disease/*blood
Biomarkers/analysis ; Biomarkers/blood ; Fibronectins/analysis ; Health Services Needs and Demand ; Humans ; Non-alcoholic Fatty Liver Disease/epidemiology
Contributed Indexing:: Keywords: Fibrosis; Insulin resistance; Irisin; Metabolic (dysfunction)-associated fatty liver disease; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis
Substance Nomenclature:: 0 (Biomarkers)
0 (FNDC5 protein, human)
0 (Fibronectins)
Entry Date(s):: Date Created: 20210621 Date Completed: 20211005 Latest Revision: 20211005
Update Code:: 20240105
DOI:: 10.1016/j.metabol.2021.154818
PMID:: 34153303
: Opinia redakcyjna

Full Text Finder

Competing Interests: Declaration of competing interest SAP, JK and ADA have no competing interests.

Informacja